The European Union has granted MSD Animal Health approval for an additional indication for the vaccine BOVILIS® INtranasal RSP®. The live intranasal vaccine can now be used in calves from the day of birth for active immunization against bovine respiratory syndrome (RBS) in Spain.
Following the decentralized approval procedure, all the countries of the European Union in which said vaccine is authorized have updated their national registries. In the case of Spain is a reality since July 2022.
BOVILIS® INtranasal RSP® is the The only vaccine authorized in the European Union against SRB that can be administered to the calf from the day of its birth. It allows farmers and veterinarians to have greater flexibility when planning vaccinations on the farm, in addition to protecting to the calf earlier against bovine respiratory syncytial virus (BRSV) and parainfluenza virus 3 (PI3) in a single intranasal vaccine.
The onset of immunity against BRSV begins six days after dosing for newborn calves and five days after dosing for one-week-old calves. The duration of immunity is 12 weeks..
“Bovine respiratory syndrome is a major threat to the health and welfare of calves that can cause pneumonia and permanent lung damage. Being one of the leading causes of morbidity in livestock populations worldwidecauses significant economic losses in the dairy and beef industries,” says Laura Elviratechnical director of ruminants at MSD Animal Health in Spain.
“Unlike other vaccination methods, intranasal vaccination remains effective in the presence of maternal antibodies found in colostrum – which a calf ingests from its mother during its first days of life -, allowing it to be effective when it is administered to a newborn animal.BOVILIS INtranasal RSP is the only vaccine that can be administered to calves from the day they are born, offering the earliest protection against SRB”, adds Elvira.
The details of the product described in the updated Technical Data Sheet (PCR) are now available at CIMAVET. You can consult it in the following link.
